Evidence map›Paper›PMID 42764453›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026

Aβ1-40 induces venular endothelial cell ferroptosis in cerebral amyloid angiopathy via the ATF3/xCT axis: Insights from single-cell RNA sequencing.

Chunmei Wu, Xiaodong Ye, Hualin Chen, Yongkang Fang, Yan Lan, Jiahe Ye, Xin Liu, Ruizhi Xiao, Suiqiang Zhu, Shanshan Huang

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chunmei Wu *Department of Neurology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, Wuhan, China.
Xiaodong Ye *Department of Neurology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Hualin Chen *Department of Geriatrics, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Yongkang FangDepartment of Neurology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Yan LanDepartment of Neurology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Jiahe YeDepartment of Neurology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Xin LiuDepartment of Neurology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Ruizhi XiaoDepartment of Neurology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Suiqiang ZhuDepartment of Neurology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Shanshan HuangDepartment of Neurology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.

Funding

China Postdoctoral Science Foundation 2025M781985Hubei Technological Innovation Special Fund (CN) 2019ACA132National Natural Science Foundation of China 82401567Natural Science Foundation of Hubei Province 2025AFB499Science Foundation of Tongji Hospital 2024A24
6 · The paper itself

Abstract

introductionAmyloid-beta (Aβ)-induced microvascular injury is a key pathological feature of cerebral amyloid angiopathy (CAA). Recent evidence suggests that ferroptosis is implicated in Aβ pathology; however, its cell-type specificity and regulatory mechanisms within the cerebral microvasculature in CAA remain unclear.

methodsSingle-cell RNA sequencing (scRNA-seq) was performed on cortical microvessels from 11-month-old APP23 mice and wild-type littermates to identify cell-type-specific ferroptosis signatures. Biochemical, histopathological, and intervention experiments were further conducted to validate the findings and investigate the underlying mechanisms.

resultsVenous endothelial cluster exhibited the most prominent enrichment of ferroptosis signatures in scRNA-seq analysis, with subsequent experiments demonstrating progressive ferroptosis-related alterations in cortical venular endothelial cells (vECs) during CAA development. Mechanistically, Aβ1-40 increased activating transcription factor 3 (ATF3) expression and its occupancy at the Slc7a11 promoter, whereas ATF3 silencing restored Slc7a11/xCT expression, supporting ATF3-mediated Slc7a11/xCT repression and consequent impairment of glutathione-dependent antioxidant defense. Importantly, endothelial ATF3 knockdown attenuated ferroptosis-related alterations in vECs, reduced cerebral Aβ burden, and ameliorated cognitive deficits in APP23 mice. DISCUSSION: This study uncovers a previously underrecognized Aβ-driven microvascular injury characterized by vEC ferroptosis and highlights the ATF3/xCT axis as a potential therapeutic target in the early stage of CAA.

Indexed as

Activating Transcription Factor 3Amino Acid Transport System y+Amyloid beta-PeptidesCerebral Amyloid AngiopathyEndothelial CellsFerroptosisPeptide FragmentsAnimalsDisease Models, AnimalMiceMice, TransgenicSequence Analysis, RNAActivating Transcription Factor 3Amino Acid Transport System y+Amyloid beta-Peptidesamyloid beta-protein (1-40)Atf3 protein, mousePeptide FragmentsSlc7a11 protein, mouseactivating transcription factor 3cerebral amyloid angiopathyferroptosissingle‐cell RNA sequencingvenular

Identifiers

PMID42764453
PMCPMC13590932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.